Overview

Treatment of Human Gingivitis With Amnion-derived Cellular Cytokine Solution (ACCS)

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of oral topical application of Amnion-derived Cellular Cytokine Solution (ACCS) in subjects with gingivitis
Phase:
Phase 1
Details
Lead Sponsor:
Noveome Biotherapeutics, formerly Stemnion
Treatments:
Pharmaceutical Solutions